137 related articles for article (PubMed ID: 24034378)
21. Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
Jacot W; Bessis D; Jorda E; Ychou M; Fabbro M; Pujol JL; Guillot B
Br J Dermatol; 2004 Jul; 151(1):238-41. PubMed ID: 15270903
[No Abstract] [Full Text] [Related]
22. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
Bierbrier R; Esfahani K; Pehr K
J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
[No Abstract] [Full Text] [Related]
23. An acneiform eruption due to erlotinib: prognostic implications and management.
Journagan S; Obadiah J
J Am Acad Dermatol; 2006 Feb; 54(2):358-60. PubMed ID: 16443077
[No Abstract] [Full Text] [Related]
24. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
25. Scalp pustules in a patient receiving chemotherapy.
Chiu HY; Chiu HC
JAMA; 2013 Sep; 310(10):1068-9. PubMed ID: 24026603
[No Abstract] [Full Text] [Related]
26. Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer.
Gholam D; Chebib A; Hauteville D; Bralet MP; Jasmin C
Anticancer Drugs; 2007 Aug; 18(7):835-7. PubMed ID: 17581308
[TBL] [Abstract][Full Text] [Related]
27. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
Magnino MZ; Perry DJ; Subramaniam DS; DeKlotz CMC
J Am Acad Dermatol; 2020 Feb; 82(2):486-488. PubMed ID: 31279812
[No Abstract] [Full Text] [Related]
28. A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.
Bierbrier R; Lam M; Pehr K
Dermatol Ther; 2022 May; 35(5):e15412. PubMed ID: 35220635
[TBL] [Abstract][Full Text] [Related]
29. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
Gencoglan G; Ceylan C
Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
[TBL] [Abstract][Full Text] [Related]
30. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
DeWitt CA; Siroy AE; Stone SP
J Am Acad Dermatol; 2007 Mar; 56(3):500-5. PubMed ID: 17166623
[TBL] [Abstract][Full Text] [Related]
31. A status report on drug-associated acne and acneiform eruptions.
Momin SB; Peterson A; Del Rosso JQ
J Drugs Dermatol; 2010 Jun; 9(6):627-36. PubMed ID: 20645524
[TBL] [Abstract][Full Text] [Related]
32. Pulsed-dye laser as an adjuvant treatment for papulopustular eruptions from epidermal growth factor receptor inhibitors, a randomized blinded split-faced controlled trial.
Rerknimitr P; Suphankong Y; Panchaprateep R; Kerr SJ; Asawanonda P
Lasers Surg Med; 2019 Sep; 51(7):584-591. PubMed ID: 30843231
[TBL] [Abstract][Full Text] [Related]
33. Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
Treudler R; Zouboulis CC
Dermatology; 2005; 211(4):375-6. PubMed ID: 16286753
[No Abstract] [Full Text] [Related]
34. Description and management of cutaneous side effects during erlotinib and cetuximab treatment in lung and colorectal cancer patients: a prospective and descriptive study of 19 patients.
de Noronha e Menezes NM; Lima R; Moreira A; Varela P; Barroso A; Baptista A; Parente B
Eur J Dermatol; 2009; 19(3):248-51. PubMed ID: 19258241
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous side-effects of EGFR inhibitors and their management.
Ehmann LM; Ruzicka T; Wollenberg A
Skin Therapy Lett; 2011 Jan; 16(1):1-3. PubMed ID: 21293833
[TBL] [Abstract][Full Text] [Related]
36. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
Andrews ED; Garg N; Patel AB
J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
[No Abstract] [Full Text] [Related]
37. A case of successfully treated recalcitrant EGFR inhibitor-induced acneiform eruption following non-ablative fractional laser.
Choi JW; Kim TI; Jeong KH; Shin MK
Dermatol Ther; 2016 Jul; 29(4):252-4. PubMed ID: 27146102
[TBL] [Abstract][Full Text] [Related]
38. Isotretinoin-induced bilateral sacroiliitis.
Bachmeyer C; Charoud A; Turc Y; Callot V; Blum L; Aractingi S
Dermatology; 2003; 206(3):285-6. PubMed ID: 12673094
[No Abstract] [Full Text] [Related]
39. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
Zhang G; Basti S; Jampol LM
Cornea; 2007 Aug; 26(7):858-60. PubMed ID: 17667622
[TBL] [Abstract][Full Text] [Related]
40. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
